Novo Nordisk CEO Says Patient Perception Is Boosting Weight-Loss Pill Growth
Novo Nordisk’s chief executive says a change in patient perception is spurring growth of the company’s weight-loss pill and bodes well for future market launches. The company launched its Wegovy pill in the U.S. earlier this year.
By Dominic ChoppingThe chief executive of Novo Nordisk says patients have changed their perception of the company's weight-loss pill, which is spurring growth of the product and bodes well for future market launches.The Danish drugmaker launched its Wegovy pill earlier this year in the U.S., making…